Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Sulfonamide compound, and preparation method and application thereof

A compound and low-level technology, applied in the field of medicine, can solve the problems of insufficient physicochemical properties of benzoazepines in terms of activity and side effects, and achieve the effect of obvious antagonism

Inactive Publication Date: 2014-08-06
TIANJIN INSTITUTE OF PHARMA RESEARCH
View PDF1 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] As drugs for the treatment of the above-mentioned diseases, benzazepine compounds still have certain deficiencies in terms of activity, side effects and physicochemical properties.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Sulfonamide compound, and preparation method and application thereof
  • Sulfonamide compound, and preparation method and application thereof
  • Sulfonamide compound, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0055]

[0056] II-1 (100g, 322mmol) was placed in a 2000mL reaction flask, and CH was added 2 Cl 2 (1000mL) was stirred to make it dissolve, added triethylamine (50g, 490mmol), stirred at room temperature, added intermediate III-1 (59.8g, 322mmol) in batches, kept the temperature and stirred for 8h, TLC detection showed that the reaction ended ( Developing agent ethyl acetate:petroleum ether=1:3).

[0057] The reaction solution was poured into 500ml of cold water, fully shaken to separate the layers, and the organic layer was separated and washed three times in succession. The organic layer was dried over anhydrous sodium sulfate and left overnight. After filtration, the solvent was evaporated to dryness under reduced pressure to obtain a light yellow solid crude product. The obtained crude product was recrystallized from ethanol to obtain 140.2 g of light yellow solid. The purity is 98.9% (HPLC normalization method), and the yield is 94.7%. ESI-MS: 460.1.

Embodiment 2

[0059]

[0060] II-1 (20g, 64mmol) was placed in a 250mL reaction flask, and CHCl was added 3 (100mL) stirred to dissolve, added pyridine (7.8g, 98mmol), stirred at 50°C, added intermediate III-2 (12.5g, 67mmol) in batches, kept the temperature and stirred for 5h, TLC detection showed that the reaction was complete (developed Agent ethyl acetate: petroleum ether = 1:3).

[0061] The reaction solution was poured into 100ml of cold water, fully shaken to separate the layers, and the organic layer was separated and washed three times in succession. The organic layer was dried over anhydrous sodium sulfate and allowed to stand overnight. After filtration, the solvent was evaporated to dryness under reduced pressure to obtain a light yellow solid crude product. The obtained crude product was purified by silica gel column chromatography to obtain 23.7 g of a white solid. The purity is 99.9% (HPLC normalization method), and the yield is 80.6%. ESI-MS: 460.1.

Embodiment 3

[0063]

[0064] Put II-2 (20g, 72mmol) in a 250mL reaction flask, add pyridine (60mL), stir to dissolve, stir at -5°C, add intermediate III-3 (15.2g, 76mmol) in batches, keep stirring at the temperature After 24 hours, TLC detection showed that the reaction was complete (developing agent ethyl acetate:petroleum ether=1:3).

[0065] The reaction solution was poured into 300ml of cold water, stirred, and solids were precipitated. After filtering, the filter cake was washed with water and dried to obtain a yellow crude product. The crude product was recrystallized from ethanol to obtain 29.5 g of white solid. The purity is 98.3% (HPLC normalization method), and the yield is 93.1%. ESI-MS: 440.2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a sulfonamide compound, and a preparation method and application thereof. Particularly, the invention relates to the sulfonamide compound with a structure shown in the formula I, an acceptable salt of the sulfonamide compound on the pharmacy, and a preparation method of the sulfonamide compound. A medicine composition uses the sulfonamide compound with the structure shown in the formula I, and the acceptable salt of the sulfonamide compound on the pharmacy as active ingredients to be used for preventing or treating diseases related to arginine vasopressin V1a receptors, arginine vasopressin V1b receptors, arginine vasopressin V2 receptors, a sympathetic nervous system or a renin-angiotensin-aldosterone system.

Description

technical field [0001] The invention belongs to the technical field of medicine, more specifically, relates to a class of sulfonamide compounds, a preparation method thereof and an application in the field of medicine. Background technique [0002] Arginine vasopressin (AVP), also known as antidiuretic hormone and vasopressin, is a peptide hormone secreted by the pituitary gland. It regulates body fluids through the receptor-G protein-second messenger pathway. Balance and other functions. AVP plays an important role in regulating the reabsorption of free water in the human body, the isotonic concentration of body fluids, blood volume, blood pressure, cell contraction, cell proliferation, and secretion of adrenal cortex hormones. [0003] Arginine vasopressin exerts various physiological effects by binding to vasopressin receptors. Vasopressin receptors can be divided into three subtypes, V1a, V1b and V2. V1a receptors are distributed in vascular smooth muscle, muscle cell...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D401/04A61K31/4545A61P9/12A61P15/00A61P15/06A61P5/38A61P9/04A61P1/16A61P25/24A61P5/00A61P7/10
CPCC07D401/04
Inventor 刘颖刘登科穆帅岳南张旭阳谭初兵周植星
Owner TIANJIN INSTITUTE OF PHARMA RESEARCH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com